ACS Chemical Neuroscience · 2017 · 63 citations · 25 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryNeuropharmacologyCytochrome P450 InteractionsDopaminergic PharmacologyEnzyme InhibitionNeurochemical PharmacologyNeurodegenerative Disease PharmacologyNeurodegenerative Disease PharmacotherapyCytochrome P450 Human Liver MicrosomesDopaminergic NeuronsEnzyme ActivityNigrostriatal Dopamine PathwayNigrostriatal Dopamine SystemParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyTyrosine Hydroxylation
To develop novel, selective, and reversible MAO-B inhibitors for safer treatment of Parkinson’s disease, benzothiazole and benzoxazole derivatives with indole moiety were designed and synthesized. Most of the synthesized compounds showed inhibitory activities against MAO-B and selectivity over MAO-A. The most active compound was compound 5b, 6-fluoro-2-(1-methyl-1 H -indol-5-yl)benzo[ d ]thiazole with an IC 50 value of 28 nM with no apparent effect on MAO-A activity at 10 μM. Based on the reversibility assay, compound 5b turned out to be fully reversible with over 95% of recovery of enzyme activity after washout of the compound. Compound 5b showed a reasonable stability in human liver microsomes and did not affect the activities of CYP isozymes, suggesting an absence of high-risk drug–drug interaction. In an in vivo MPTP-induced animal model of Parkinson’s disease, oral administration of compound 5b showed neuroprotection of nigrostriatal dopaminergic neurons as revealed by tyrosine hydroxylase staining and prevention of MPTP-induced parkinsonism as revealed by motor behavioral assay of vertical grid test. In summary, the novel, reversible, and selective MAO-B inhibitor compound 5b was synthesized and characterized. We propose compound 5b as an effective therapeutic compound for relieving parkinsonism.
25
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson‐Lewis, Serge Przedborski · Nature Protocols · 2007 · 1.1K citations
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Seonmi Jo, Oleg Yarishkin, Yu Jin Hwang et al. · Nature Medicine · 2014 · 773 citations · Full text